Siga este link para ver outros tipos de publicações sobre o tema: Canadian Health Coalition.
Artigos de revistas sobre o tema "Canadian Health Coalition"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Canadian Health Coalition".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
1
Arehart-Treichel, Joan. "Canadian Coalition Develops Mental Health Action Plan". Psychiatric News 38, n.º 8 (18 de abril de 2003): 48–49. http://dx.doi.org/10.1176/pn.38.8.0048.
Texto completo da fonte
2
Malach, Faith, e Kimberley Wilson. "Canadian Coalition for Seniors’ Mental Health 2nd National Conference". Aging Health 3, n.º 6 (dezembro de 2007): 707–10. http://dx.doi.org/10.2217/1745509x.3.6.707.
Texto completo da fonte
3
Rouleau, Jean L. "CSCI/RCPSC HENRY FRIESEN LECTURE: Clinical research in Canada: the dawn of a new era?" Clinical & Investigative Medicine 32, n.º 5 (1 de outubro de 2009): 395. http://dx.doi.org/10.25011/cim.v32i5.6928.
Texto completo da fonteResumo:
In response to the growing gap between discovery and the optimal application of medical advancements to health care delivery, countries the world over have developed large and well funded programs to reduce these gaps. Although these programs vary in nature, they have generally largely focused more on reducing the gap in bench to bedside research. Canada’s strong biomedical and patient oriented research (POR) community has a strong base from which to build, but requires support in order to fill the missing elements needed to take full advantage of the important unmet needs in health related research. In Canada, a coalition of funders of medical research, led by the Canadian Institutes for Health Research (CIHR) is developing a large and comprehensive program to build a Canadian infrastructure that will provide these missing elements, and further strengthen POR in Canada. This coalition proposes to put particular emphasis on bedside to community POR, including phase 3 clinical trials, to take advantage of and improve the sustainability of Canada’s unique universal health care system. The major initiatives in POR developed by so many countries, including Canada clearly heralds a new era in clinical research, one that the Canadian research community needs to take full advantage of.
4
Waddington, Kent, e Linda Varangu. "Canadian Coalition for Green Health Care Leading the Evolution of Green". Healthcare Quarterly 19, n.º 3 (31 de outubro de 2016): 23–29. http://dx.doi.org/10.12927/hcq.2016.24869.
Texto completo da fonte
5
Checkland, Claire, Sophiya Benjamin, Marie-Andrée Bruneau, Antonia Cappella, Beverley Cassidy, David Conn, Cindy Grief et al. "Position Statement for Mental Health Care in Long-Term Care During COVID-19". Canadian Geriatrics Journal 24, n.º 4 (1 de dezembro de 2021): 367–72. http://dx.doi.org/10.5770/cgj.24.514.
Texto completo da fonteResumo:
COVID-19 has disproportionately impacted older adults in long-term care (LTC) facilities in Canada. There are opportunities to learn from this crisis and to improve systems of care in order to ensure that older adults in LTC enjoy their right to the highest attainable standard of health. Measures are needed to ensure the mental health of older adults in LTC during COVID-19. The Canadian Academy of Geriatric Psychiatry (CAGP) and Canadian Coalition for Seniors’ Mental Health (CCSMH) have developed the following position statements to address the mental health needs of older adults in LTC facilities, their family members, and LTC staff. We outlined eight key considerations related to mental health care in LTC during COVID-19 to optimize the mental health of this vulnerable population during the pandemic.
6
Bertram, Jonathan R., Amy Porath, Dallas Seitz, Harold Kalant, Ashok Krishnamoorthy, Andra Smith e Rand Teed. "Canadian Guidelines on Cannabis Use Disorder Among Older Adults". Canadian Geriatrics Journal 23, n.º 1 (13 de março de 2020): 135–42. http://dx.doi.org/10.5770/cgj.23.424.
Texto completo da fonteResumo:
BackgroundCannabis Use Disorder (CUD) is an emerging and diverse challenge among older adults.MethodsThe Canadian Coalition for Seniors’ Mental Health, with financial support from Health Canada, has produced evidencebased guidelines on the prevention, identification, assessment, and treatment of this form of substance use disorder.ConclusionsOlder adults may develop CUD in the setting of recreational and even medical use. Clinicians should remain vigilant for the detection of CUD, and they should be aware of strategies for prevention and managing its emergence and consequences The full version of these guidelines can be accessed at www.ccsmh.ca.
7
Proulx, L., S. Stones, J. Coe, D. Richards, L. Wilhelm, N. Robertson, J. Gunderson, A. Sirois e A. Mckinnon. "OP0196-PARE #ARTHRITISATWORK: USING TWITTER TO ENGAGE THE INTERNATIONAL ARTHRITIS COMMUNITY". Annals of the Rheumatic Diseases 79, Suppl 1 (junho de 2020): 122. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4793.
Texto completo da fonteResumo:
Background:In 2019, EULAR launched the #Time2Work campaign [1] to raise awareness of the impact of rheumatic and musculoskeletal diseases on individuals, society, and the economy. Building on this theme, the Canadian Arthritis Patient Alliance (CAPA) developed a social media campaign and Twitter chat in collaboration with international patient advocates and organizations. The Twitter chat built upon CAPA’s successful development of workplace resources for people living with arthritis [2].Objectives:To deliver an international #ArthritisAtWork social media campaign on Twitter, in support of the #Time2Work campaign.Methods:A one-hour Twitter Chat was held on World Arthritis Day (October 12, 2019) on arthritis in the workplace (#ArthritisAtWork) from 18:00 to 19:00 UTC. The chat was hosted by CAPA and co-hosted by Simon Stones, a patient advocate from the United Kingdom (UK) and CreakyJoints, patient-driven arthritis organization in the United States (US). The Twitter Chat questions were co-developed in advance by the hosts, and blog posts were shared from CAPA’s website. Each host also promoted the Twitter Chat through their websites, newsletters and online communities. A social media analytical tool, Symplur, was used to measure audience engagement using the hashtag #ArthritisAtWork. In addition, pertinent Tweets before, during, and after the chat were obtained. The analysis of themes was undertaken to identify common issues and questions.Results:One hundred and ten users participated in the Twitter chat between 17:20 and 19:20 UTC. Participants included people living with arthritis, researchers, patient organizations, health information outlets and academic institutions. During this period, 565 tweets were shared between participants in Australia, Canada, Ireland, Spain, UK and US. There were 3.352 million Twitter impressions. This represents the number of times a tweet appears to users in either their timeline or search results. Emergent themes of the analysis include:common workplace challenges such as employer attitudes and stigma;effective workplace supports such as prioritizing tasks and requesting workplace accommodations; andareas of improvement such as instituting workplace policies, flexible workplace approaches and education for employees and managers.Conclusion:The social media campaign was successful in reaching a diverse audience and supporting the #Time2Work campaign. Social media tools can provide an important social support for people living with arthritis as they navigate workplace challenges. It also offers a more contemporary platform to engage the international community on issues of common interest. Working together, internationally helps expand reach and reduce barriers in communication. Research can be conducted to measure potential behavior change that leverages digital social support for people living with arthritis.References:[1]EULAR (2019). Press release “EULAR launches Time2Work campaign to highlight the importance of keeping people with rheumatic and musculoskeletal diseases in work. Available from:https://www.eular.org/sysModules/obxContent/files/www.eular.2015/1_42291DEB-50E5-49AE-5726D0FAAA83A7D4/time2work_campaign_press_release_final.pdf2. CAPA (2019). Arthritis in the Workplace: Resources for Patients by Patients. Available from:http://arthritispatient.ca/arthritis-in-the-workplace-resources-for-patients-by-patients/Disclosure of Interests:Laurie Proulx Grant/research support from: Sources of grants and support received by the Canadian Arthritis Patient Alliance (including in-kind support) in the last two years include: AbbVie Canada, Alliance for Safe Biologic Medicines, Amgen Canada, Arthritis Alliance of Canada, The Arthritis Society, Best Medicines Coalition, CADTH, Canadian Rheumatology Association, Eli Lilly Canada, European League Against Rheumatism, Janssen Canada, Manulife, Novartis Canada, Ontario Rheumatology Association, Pfizer Canada (including Pfizer Hospira), Purdue Pharma Canada, Sanofi, and UCB Pharma., Speakers bureau: I have provided speaking services to Sanofi and Eli Lilly. These engagements do not relate to this abstract., Simon Stones Consultant of: I have been a paid consultant for Envision Pharma Group and Parexel. This does not relate to this abstract., Speakers bureau: I have been a paid speaker for Actelion and Janssen. These do not relate to this abstract., Joseph Coe: None declared, Dawn Richards Grant/research support from: Sources of grants and support received by the Canadian Arthritis Patient Alliance (including in-kind support) in the last two years include: AbbVie Canada, Alliance for Safe Biologic Medicines, Amgen Canada, Arthritis Alliance of Canada, The Arthritis Society, Best Medicines Coalition, CADTH, Canadian Rheumatology Association, Eli Lilly Canada, European League Against Rheumatism, Janssen Canada, Manulife, Novartis Canada, Ontario Rheumatology Association, Pfizer Canada (including Pfizer Hospira), Purdue Pharma Canada, Sanofi, and UCB Pharma., Consultant of: Dawn has done small consulting projects on patient engagement for companies., Speakers bureau: Dawn has been a paid speaker for several companies., Linda Wilhelm Grant/research support from: Sources of grants and support received by the Canadian Arthritis Patient Alliance (including in-kind support) in the last two years include: AbbVie Canada, Alliance for Safe Biologic Medicines, Amgen Canada, Arthritis Alliance of Canada, The Arthritis Society, Best Medicines Coalition, CADTH, Canadian Rheumatology Association, Eli Lilly Canada, European League Against Rheumatism, Janssen Canada, Manulife, Novartis Canada, Ontario Rheumatology Association, Pfizer Canada (including Pfizer Hospira), Purdue Pharma Canada, Sanofi, and UCB Pharma., Nathalie Robertson Grant/research support from: Sources of grants and support received by the Canadian Arthritis Patient Alliance (including in-kind support) in the last two years include: AbbVie Canada, Alliance for Safe Biologic Medicines, Amgen Canada, Arthritis Alliance of Canada, The Arthritis Society, Best Medicines Coalition, CADTH, Canadian Rheumatology Association, Eli Lilly Canada, European League Against Rheumatism, Janssen Canada, Manulife, Novartis Canada, Ontario Rheumatology Association, Pfizer Canada (including Pfizer Hospira), Purdue Pharma Canada, Sanofi, and UCB Pharma., Janet Gunderson Grant/research support from: Sources of grants and support received by the Canadian Arthritis Patient Alliance (including in-kind support) in the last two years include: AbbVie Canada, Alliance for Safe Biologic Medicines, Amgen Canada, Arthritis Alliance of Canada, The Arthritis Society, Best Medicines Coalition, CADTH, Canadian Rheumatology Association, Eli Lilly Canada, European League Against Rheumatism, Janssen Canada, Manulife, Novartis Canada, Ontario Rheumatology Association, Pfizer Canada (including Pfizer Hospira), Purdue Pharma Canada, Sanofi, and UCB Pharma., Alexandra Sirois Grant/research support from: Sources of grants and support received by the Canadian Arthritis Patient Alliance (including in-kind support) in the last two years include: AbbVie Canada, Alliance for Safe Biologic Medicines, Amgen Canada, Arthritis Alliance of Canada, The Arthritis Society, Best Medicines Coalition, CADTH, Canadian Rheumatology Association, Eli Lilly Canada, European League Against Rheumatism, Janssen Canada, Manulife, Novartis Canada, Ontario Rheumatology Association, Pfizer Canada (including Pfizer Hospira), Purdue Pharma Canada, Sanofi, and UCB Pharma., Annette McKinnon Grant/research support from: Sources of grants and support received by the Canadian Arthritis Patient Alliance (including in-kind support) in the last two years include: AbbVie Canada, Alliance for Safe Biologic Medicines, Amgen Canada, Arthritis Alliance of Canada, The Arthritis Society, Best Medicines Coalition, CADTH, Canadian Rheumatology Association, Eli Lilly Canada, European League Against Rheumatism, Janssen Canada, Manulife, Novartis Canada, Ontario Rheumatology Association, Pfizer Canada (including Pfizer Hospira), Purdue Pharma Canada, Sanofi, and UCB Pharma.
8
Authors, Various. "CAGP-CCSMH Annual Scientific Meeting Canadian Academy of Geriatric Psychiatry and Canadian Coalition for Seniors’ Mental Health". Canadian Geriatrics Journal 21, n.º 4 (10 de dezembro de 2018): 320–42. http://dx.doi.org/10.5770/cgj.21.356.
Texto completo da fonte
9
Mathura, Pamela, Sandra Marini, Reidar Hagtvedt, Karen Spalding, Lenora Duhn, Narmin Kassam e Jennifer Medves. "Factors of a physician quality improvement leadership coalition that influence physician behaviour: a mixed methods study". BMJ Open Quality 12, n.º 2 (junho de 2023): e002016. http://dx.doi.org/10.1136/bmjoq-2022-002016.
Texto completo da fonteResumo:
BackgroundA coalition (Strategic Clinical Improvement Committee), with a mandate to promote physician quality improvement (QI) involvement, identified hospital laboratory test overuse as a priority. The coalition developed and supported the spread of a multicomponent initiative about reducing repetitive laboratory testing and blood urea nitrogen (BUN) ordering across one Canadian province. This study’s purpose was to identify coalition factors enabling medicine and emergency department (ED) physicians to lead, participate and influence appropriate BUN test ordering.MethodsUsing sequential explanatory mixed methods, intervention components were grouped as person focused or system focused. Quantitative phase/analyses included: monthly total and average of the BUN test for six hospitals (medicine programme and two EDs) were compared pre initiative and post initiative; a cost avoidance calculation and an interrupted time series analysis were performed (participants were divided into two groups: high (>50%) and low (<50%) BUN test reduction based on these findings). Qualitative phase/analyses included: structured virtual interviews with 12 physicians/participants; a content analysis aligned to the Theoretical Domains Framework and the Behaviour Change Wheel. Quotes from participants representing high and low groups were integrated into a joint display.ResultsMonthly BUN test ordering was significantly reduced in 5 of 6 participating hospital medicine programmes and in both EDs (33% to 76%), resulting in monthly cost avoidance (CAN$900–CAN$7285). Physicians had similar perceptions of the coalition’s characteristics enabling their QI involvement and the factors influencing BUN test reduction.ConclusionsTo enable physician confidence to lead and participate, the coalition used the following: a simply designed QI initiative, partnership with a coalition physician leader and/or member; credibility and mentorship; support personnel; QI education and hands-on training; minimal physician effort; and no clinical workflow disruption. Implementing person-focused and system-focused intervention components, and communication from a trusted local physician—who shared data, physician QI initiative role/contribution and responsibility, best practices, and past project successes—were factors influencing appropriate BUN test ordering.
10
Rapoport, Mark, e Benoit H. Mulsant. "Pathway to prevention: great progress has been made but we are not yet there". International Psychogeriatrics 22, n.º 8 (29 de setembro de 2010): 1193–95. http://dx.doi.org/10.1017/s1041610210001882.
Texto completo da fonteResumo:
In September 2009, Montreal, Quebec hosted the International Psychogeriatric Association's 14th International Congress, in collaboration with the American Association for Geriatric Psychiatry, the Canadian Academy of Geriatric Psychiatry, the Canadian Coalition for Seniors' Mental Health, the Canadian Geriatrics Society, and the Société Québecoise de Psychogériatrie. The theme of the Congress was the “Pathway to Prevention”, and the presentations focused on progress made to date on the prevention of late-life mental disorders, barriers the field is still facing, and future achievements that will be needed for this goal to be achieved.
11
Bartram, Mary. "Expanding access to psychotherapy in Canada: Building on achievements in Australia and the United Kingdom". Healthcare Management Forum 32, n.º 2 (30 de janeiro de 2019): 63–67. http://dx.doi.org/10.1177/0840470418818581.
Texto completo da fonteResumo:
Australia and the United Kingdom have significantly expanded access to psychotherapy over the past decade. With this international experience to draw upon and a new $5 billion federal mental health transfer, Canada is well positioned to address long-standing gaps and inequities in access to psychotherapy. In Canada’s more decentralized context, a concerted effort from health leaders at all levels of government and across multiple sectors and professions is needed to make the most of this opportunity for reform. Key priorities for health leaders include using the full range of provincial and territorial policy levers for either a grants-based or insurance-based approach; implementing a strong approach to performance monitoring, with equity targets built in from the outset; addressing gaps in workforce planning; and forming a pan-Canadian coalition for expanding access to psychotherapy.
12
Buckley, Norm, e Jason Busse. "The opioid crisis in canada – Governmental responses and strategies". Open Access Government 42, n.º 1 (15 de abril de 2024): 62–163. http://dx.doi.org/10.56367/oag-042-10665.
Texto completo da fonteResumo:
The opioid crisis in canada – Governmental responses and strategies Norm Buckley, Scientific Director at the Michael G. DeGroote Institute for Pain Research & Care, and Jason Busse, Director of the Michael G DeGroote National Pain Centre at McMaster University, discuss the complexities of chronic pain management and addressing the opioid crisis. The National Advisory Council on Prescription Drug Misuse was formed to address the opioid crisis in Canada. Led by the Canadian Centre on Substance Abuse (now known as the Canadian Centre on Substance Abuse and Addiction), the Coalition on Prescription Drug Misuse (Alberta), and the Nova Scotia Department of Health and Wellness, in partnership with Health Canada’s First Nations and Inuit Health Branch’s Prescription Drug Abuse Coordinating Committee (PDACC), the Council released First Do No Harm: Responding to Canada’s Prescription Drug Crisis in March 2013. Half of the recommendations addressed issues regarding chronic pain, recognizing the link between opioid prescribing and chronic pain. The Council recommended establishing competencies for healthcare professionals, improving healthcare professional curricula for pain and addiction, ensuring access to optimal care for pain as well as addiction, and supporting research that would optimize evidence-based care of patients.
13
Rieb, Launette M., Zainab Samaan, Andrea D. Furlan, Kiran Rabheru, Sid Feldman, Lillian Hung, George Budd e Douglas Coleman. "Canadian Guidelines on Opioid Use Disorder Among Older Adults". Canadian Geriatrics Journal 23, n.º 1 (13 de março de 2020): 123–34. http://dx.doi.org/10.5770/cgj.23.420.
Texto completo da fonteResumo:
BackgroundIn Canada, rates of hospital admission from opioid overdose are higher for older adults (≥ 65) than younger adults, and opioid use disorder (OUD) is a growing concern. In response, Health Canada commissioned the Canadian Coalition of Seniors’ Mental Health to create guidelines for the prevention, screening, assessment, and treatment of OUD in older adults.MethodsA systematic review of English language literature from 2008–2018 regarding OUD in adults was conducted. Previously published guidelines were evaluated using AGREE II, and key guidelines updated using ADAPTE method, by drawing on current literature. Recommendations were created and assessed using the GRADE method.ResultsThirty-two recommendations were created. Prevention recommendations: it is key to prioritize non-pharmacological and non-opioid strategies to treat acute and chronic noncancer pain. Assessment recommendations: a comprehensive assessment is important to help discern contributions of other medical conditions. Treatment recommendations: buprenorphine is first line for both withdrawal management and maintenance therapy, while methadone, slow-release oral morphine, or naltrexone can be used as alternatives under certain circumstances; non-pharmacological treatments should be offered as an integrated part of care.ConclusionThese guidelines provide practical and timely clinical recommendations on the prevention, assessment, and treatment of OUD in older adults within the Canadian context.
14
Trytten, Cindy, Martin Wale, Michael Hayes e Bev Holmes. "Lessons learned from a health authority research capacity-building initiative". Healthcare Management Forum 32, n.º 5 (11 de julho de 2019): 259–65. http://dx.doi.org/10.1177/0840470419849468.
Texto completo da fonteResumo:
Health systems worldwide are under pressure to deliver better care to more people with increasingly complex needs within constrained budgets. Research capacity building has been shown to help alleviate these challenges and is underway at hospitals and health authorities across the country; however, approaches vary widely and little exists in the Canadian literature to share experience and best practices. This article describes how a health authority in British Columbia, Canada, implemented and evaluated a 5-year research capacity-building program in partnership with a provincial health research funder. We offer lessons learned for those leading similar innovation-focused change management initiatives, including vision and buy in, complexity thinking, infrastructure, leadership, and coalition development. We suggest that collective learning and building a more robust research capacity-building literature can help health organizations and their partners take significant steps toward integrating research and care for a more effective, efficient, and patient-centred health system.
15
Conn, David K., David B. Hogan, Lori Amdam, Keri-Leigh Cassidy, Peter Cordell, Christopher Frank, David Gardner et al. "Canadian Guidelines on Benzodiazepine Receptor Agonist Use Disorder Among Older Adults". Canadian Geriatrics Journal 23, n.º 1 (13 de março de 2020): 116–22. http://dx.doi.org/10.5770/cgj.23.419.
Texto completo da fonteResumo:
Background
Benzodiazepine receptor agonist (BZRA) use disorder among older adults is a relatively common and challenging clinical condition.
Method
The Canadian Coalition for Seniors’ Mental Health, with financial support from Health Canada, has produced evidencebased guidelines on the prevention, identification, assessment, and management of this form of substance use disorder.
Results
Inappropriate use of BZRAs should be avoided by considering non-pharmacological approaches to the management of late life insomnia, anxiety, and other common indications for the use of BZRA. Older persons should only be prescribed BZRAs after they are fully informed of alternatives, benefits, and risks associated with their use. Clinicians should have a high index of suspicion for the presence of BZRA use disorders. The full version of these guidelines can be accessed at www.ccsmh.ca
Conclusions
A person-centred, stepped care approach utilizing gradual dose reductions should be used in the management of BZRA use disorder.
16
McCormack, Thelma. "Fetal Syndromes and the Charter: The Winnipeg Glue-Sniffing Case". Canadian journal of law and society 14, n.º 2 (1999): 77–99. http://dx.doi.org/10.1017/s0829320100006074.
Texto completo da fonteResumo:
AbstractThe relationship between scientific knowledge and legal discourse is raised once again by a recent decision of the Supreme Court of Canada, a case involving a young Aboriginal woman who was pregnant and ordered by the court to remain in a drug treatment program at a health center until the baby was born. Her glue-sniffing habit was deemed dangerous to the normal development of the fetus. The Court held that her solvent-dependency did not justify the original court action, but both the Court and the various interveners disregarded the current state of our knowledge on the fetal syndromes. There is thus a continuing disconnect between the scientific understanding of fetal risk and the development of Constitutional law around women's reproductive rights. This paper reviews the case and follows it through the appellate process; we examine the research literature on fetal syndromes tracking the changes over time. Finally we comment on the interventions by the Winnipeg Child and Family Services, the Women's Health Rights Coalition, by The Canadian Civil Liberties Association, and both The Canadian Abortion Rights Action League and the Women's Legal Education and Action Fund.
17
Butt, Peter R., Marilyn White-Campbell, Sarah Canham, Ann Dowsett Johnston, Eunice O. Indome, Bonnie Purcell, Jennifer Tung e Lisa Van Bussel. "Canadian Guidelines on Alcohol Use Disorder Among Older Adults". Canadian Geriatrics Journal 23, n.º 1 (13 de março de 2020): 143–48. http://dx.doi.org/10.5770/cgj.23.425.
Texto completo da fonteResumo:
BackgroundAlcohol use disorder (AUD) is an increasingly common, under-recognized, and under-treated health concern in older adults. Its prevalence is expected to reach unprecedented levels as the Canadian population ages. In response, Health Canada commissioned the Canadian Coalition of Seniors’ Mental Health to create guidelines for the prevention, screening, assessment, and treatment of AUD in older adults.MethodsA systematic review of English language literature from 2008–2018 regarding AUD in adults was conducted. Previously published guidelines were evaluated using AGREE II, and key guidelines updated using ADAPTE method by drawingon current literature. Recommendations were created and assessed using the GRADE method.ResultsTwenty-two recommendations were created. Prevention recommendations: Best advice for older adults who choose to drink is to limit intake to well below the national Low-Risk Alcohol Drinking Guidelines. Screening recommendations: Alcohol consumption should be reviewed and discussed on an annual basis by primary care providers. This type of discussion needs to be normalized and approached in a simple, neutral, straight-forward manner. Assessment recommendations: Positive screens for AUD should be followed by a comprehensive assessment. Once more details are obtained an individualized treatment plan can be recommended, negotiated,and implemented. Treatment recommendations: AUD falls on a spectrum of mild, moderate, and severe. Itcan also be complicated by concurrent mental health, physical, or social issues, especially in older adults. Naltrexone and Acamprosate pharmacotherapies can be used for the treatment of AUD in older adults, as individually indicated. Psychosocial treatment and support should be offered as part of a comprehensive treatment plan.
18
Conn, David, Lisa Sokoloff, Claire Checkland, Jasmeen Guraya, Vivian Ewa, Sid Feldman, Cindy Grief et al. "431 - Establishing a Canadian National ECHO Educational Program focused on Mental Health of Older Adults". International Psychogeriatrics 33, S1 (outubro de 2021): 50–51. http://dx.doi.org/10.1017/s1041610221001903.
Texto completo da fonteResumo:
BackgroundProject ECHO is a virtual, case-based capacity-building education program for healthcare providers. It was developed in New Mexico, USA but, due to its effectiveness, the model has now spread to 40 countries around the globe. Baycrest, the Canadian Coalition for Seniors’ Mental Health and the Canadian Academy of Geriatric Psychiatry collaborated to launch a national ECHO for mental health and aging. This partnership, coordinated by a cross-Canadian Steering Group, allows for broad reach, including registration of learning partners from almost all Canadian provinces and territories. The program was funded by the RBC Foundation.MethodsECHO COE: Mental Health pilot consisted of 2 cycles: 6 weekly sessions focused on broader mental health topics (e.g., delirium, mood disorders)10 weeks with more specific topics (e.g., substance use disorders, sleep disorders)Needs assessments of healthcare providers and older adults informed the program curricula. Evaluation included weekly satisfaction surveys, and pre and post evaluations.ResultsParticipants: 154 healthcare providers participated in the 6-week session39% of registrants were nurses or nurse practitioners, 35% allied health professionals, 14% physicians and 12% others9 out of 10 provinces, 1 territory representedPreliminary findings (based on the first 6 sessions): High overall satisfaction (average of 4.5 out of 5).99% would recommend the program to others67% had already shared information with team members and colleagues.ConclusionA national ECHO program is an effective way to bring together clinicians who work with and are interested in the mental health and wellbeing of older adults for education sessions, collaborative and mutual learning as well as for cross-jurisdictional knowledge transfer. Collaborative, cross-professional learning supports the exchange of best practice in mental health for older adults, supports the development of collegial national professional support and can address health system inequities. An international ECHO through IPA would be an exciting and valuable next step.
19
Hyett, Sarah Louise, Chelsea Gabel, Stacey Marjerrison e Lisa Schwartz. "Deficit-Based Indigenous Health Research and the Stereotyping of Indigenous Peoples". Canadian Journal of Bioethics 2, n.º 2 (20 de março de 2019): 102–9. http://dx.doi.org/10.7202/1065690ar.
Texto completo da fonteResumo:
Health research tends to be deficit-based by nature; as researchers we typically quantify or qualify absence of health markers or presence of illness. This can create a narrative with far reaching effects for communities already subject to stigmatization. In the context of Indigenous health research, a deficit-based discourse has the potential to contribute to stereotyping and marginalization of Indigenous Peoples in wider society. This is especially true when researchers fail to explore the roots of health deficits, namely colonization, Westernization, and intergenerational trauma, risking conflation of complex health challenges with inherent Indigenous characteristics. In this paper we explore the incompatibility of deficit-based research with principles from several ethical frameworks including the Tri-Council Policy Statement (TCPS2) Chapter 9, OCAP® (ownership, control, access, possession), Inuit Tapiriit Kanatami National Inuit Strategy on Research, and Canadian Coalition for Global Health Research (CCGHR) Principles for Global Health Research. Additionally we draw upon cases of deficit-based research and stereotyping in healthcare, in order to identify how this relates to epistemic injustice and explore alternative approaches.
20
Beatson, Jesse. "The Stories We Tell about Refugee Claimants: Contested Frames of the Health-Care Access Question in Canada". Refuge: Canada's Journal on Refugees 32, n.º 3 (23 de novembro de 2016): 125–34. http://dx.doi.org/10.25071/1920-7336.40370.
Texto completo da fonteResumo:
A contested issue is the extent to which refugee claimants should have access to health care in Western host countries with publicly subsidized health-care systems. In Canada, for a period of over fifty years, the federal government provided relatively comprehensive health coverage to refugees and refugee claimants through the Interim Federal Health Plan (IFHP). Significant cuts to the IFHP were implemented in June 2012 by the Conservative federal government (2006–15), who justified these cuts through public statements portraying refugee claimants as bring- ing bogus claims that inundate the refugee determination system. A markedly different narrative was articulated by a pan-Canadian coalition of health providers who characterized refugee claimants as innocent victims done further harm by inhumane health-care cuts. This article presents an analysis of these two positions in terms of frame theory, with a greater emphasis on the health-provider position. This debate can be meaningfully analyzed as a contest between competing frames: bogus and victim. Frame theory suggests that frames by nature simplify and condense, in this case packaging complex realities about refugee claimants into singular images (bogus and victim), aiming to inspire suspicion and compassion respectively. It will be argued that the acceptance of current frames impoverishes the conversation by reinforcing problematic notions about refugee claimants while also obscuring a rights-based argument for why claimants should have substantial access to health care.
21
Robitaille, Marie-Chantal, Mélissa Mialon e Jean-Claude Moubarac. "The bio-food industry’s corporate political activity during Health Canada’s revision of Canada’s food guide". Health Promotion and Chronic Disease Prevention in Canada 43, n.º 12 (dezembro de 2023): 485–98. http://dx.doi.org/10.24095/hpcdp.43.12.01.
Texto completo da fonteResumo:
Introduction We analyzed the bio-food industry’s corporate political activity (CPA) during the revisions of Canada’s food guide between 2016 and 2019. Methods We undertook a content analysis of the websites of 11 bio-food industry organizations and of the briefs that 10 of them submitted to the Canadian House of Commons Standing Committee on Health, as part of this Committee’s review of the food guide. Data were classified according to an existing conceptual framework. Results We identified 366 examples of CPA used by the bio-food industry during and immediately after the development of the food guide. Most of the industry actors opposed the guide’s recommendations. The most common CPA strategies were information management (n = 197), used to create and disseminate information in industry’s favour, and discursive strategies (n = 108), used to defend food products and promote the industry’s position regarding the food guide. Influencing public policy (n = 40), by gaining indirect access to policy makers (e.g. through lobbying) and becoming active in government decision-making, as well as coalition management (n = 21), by establishing relationships with opinion leaders and health organizations, were also common strategies. Conclusion Bio-food industry actors used many different CPA strategies during the revisions of the food guide. It is important to continue to document the bio-food industry’s CPA to understand whether and how this is shaping public policy development in Canada and elsewhere.
22
Chockalingam, Arun, Marilyn Bacher, Norman Campbell, Heather Cutler, Aidan Drover, Ross Feldman, George Fodor et al. "Adherence to Management of High Blood Pressure: Recommendations of the Canadian Coalition for High Blood Pressure Prevention and Control". Canadian Journal of Public Health 89, n.º 5 (setembro de 1998): I5—I7. http://dx.doi.org/10.1007/bf03404491.
Texto completo da fonte
23
Mann, Janice, Sohail Mulla e Sirjana Pant. "OP92 Non-Opioid Therapy For Pain Management – Health Technology Assessment In A Time Of Crisis". International Journal of Technology Assessment in Health Care 34, S1 (2018): 34. http://dx.doi.org/10.1017/s0266462318001265.
Texto completo da fonteResumo:
Introduction:North America is facing a public health epidemic – the opioid crisis – part of which is attributed to the inappropriate use of opioids in pain management. As such, the 2017 Canadian Guideline for Opioids for Chronic Non-Cancer Pain recommends optimizing non-opioid pharmacotherapy or non-pharmacological therapy to treat chronic pain, before a trial of opioids. However, the Guideline itself is not designed to provide evidence on the effectiveness of these non-opioid alternatives, leaving a gap for those attempting to put the recommendation into practice.Methods:In collaboration with its partners, including clinicians and policymakers, the Canadian Agency for Drugs and Technologies (CADTH) identified the gaps in evidence, and developed an action plan to bridge the evidence gaps to support the optimization of non-opioid alternatives in pain management.Results:Since the release of the Guideline, CADTH produced over 20 Rapid Response reports that synthesize and appraise evidence on non-opioid alternatives in the management of a wide range of pain, both acute and chronic. Additionally, CADTH has also reviewed evidence on multidisciplinary pain treatment programs, and is developing environmental scan reports on the availability and access to non-pharmacological treatments for pain in Canada, and on drugs for emerging non-opioid pain. Further, CADTH developed knowledge mobilization tools based on the evidence reviews. The evidence reviews and tools are used as a resource by CADTH partners, including the Coalition of Safe and Effective Pain Management and McMaster University National Pain Center.Conclusions:This presentation will discuss the role of HTA and CADTH to fill the gaps in evidence for a crucial clinical practice guideline recommendation in a time of public health crisis, and help put the evidence into action. It will present the evidence synthesized by CADTH on various non-opioid alternatives for pain management, while highlighting the remaining gaps in evidence. Understanding the evidence on non-opioid alternatives will inform clinical and policy decisions and potentially reduce inappropriate use of opioids in pain management.
24
D'Aubin, April. "Personal Services: A Challenge for the Nineties". Canadian Journal of Community Mental Health 9, n.º 2 (1 de setembro de 1990): 9–17. http://dx.doi.org/10.7870/cjcmh-1990-0015.
Texto completo da fonteResumo:
The lifestyles of people with disabilities have been changing rapidly during the last two decades. While in the past people with disabilities tended to remain within the confines of institutions for most of their lives, disabled citizens are now participating in all aspects of community life. Today disabled women and men are marrying, raising families, pursuing a variety of career options, doing volunteer work, and travelling. Many disabled people who lead challenging lifestyles also require personal services which are provided by readers, attendants, homemakers, resource facilitators, and job-site coaches. Consumers are finding that existing delivery systems either fail to meet their needs or unduly constrain their lifestyles. Consequently, people with disabilities have developed a strategy for how personal services should be delivered, and the Coalition of Provincial Organizations of the Handicapped's (COPOH) perspective on this issue is elucidated in this article. This report attempts to convey the concerns which have been raised at various consumer forums in personal testimonies by men and women with disabilities. This is in keeping with COPOH's role as the disabled consumer's voice in Canadian society.
25
Moutier, Christine Y., David E. J. Bazzo e William A. Norcross. "Approaching the Issue of the Aging Physician Population". Journal of Medical Regulation 99, n.º 1 (1 de março de 2013): 10–18. http://dx.doi.org/10.30770/2572-1852-99.1.10.
Texto completo da fonteResumo:
ABSTRACT In November 2011, the Coalition for Physician Enhancement (CPE) and the University of California, San Diego, Physician Assessment and Clinical Education (PACE) Program held a conference on the issue of physician aging and its potential impact on clinical performance and quality of care. Speakers and attendees from the United States and Canada reviewed a variety of topics and trends related to aging. Data reviewed during the conference reveal that average physician age is increasing, and while a variety of positive aspects of aging can provide a professional benefit, some studies associate a decrease in physician performance with increasing age. Among the factors that can affect physician performance include solo practice, lack of American Board of Medical Specialties (ABMS) Board Certification, practicing outside the scope of training, high clinical volume and health issues. Conference attendees examined Canadian experiences with age-based competency screening and participated in a survey of opinion regarding age-based screening. The majority favored age-based screening beginning at the age of 70, using a system that would include assessments of physical and mental health and a cognitive screen. Competency screening could include peer review and practice evaluation methods. The authors propose further study of age-based screening and encourage physicians to think carefully about the timing of appropriate modifications to and retirement from practice.
26
Gray, Gregory C., e Han K. Kang. "Healthcare utilization and mortality among veterans of the Gulf War". Philosophical Transactions of the Royal Society B: Biological Sciences 361, n.º 1468 (24 de março de 2006): 553–69. http://dx.doi.org/10.1098/rstb.2006.1816.
Texto completo da fonteResumo:
The authors conducted an extensive search for published works concerning healthcare utilization and mortality among Gulf War veterans of the Coalition forces who served during the1990–1991 Gulf War. Reports concerning the health experience of US, UK, Canadian, Saudi and Australian veterans were reviewed. This report summarizes 15 years of observations and research in four categories: Gulf War veteran healthcare registry studies, hospitalization studies, outpatient studies and mortality studies. A total of 149 728 (19.8%) of 756 373 US, UK, Canadian and Australian Gulf War veterans received health registry evaluations revealing a vast number of symptoms and clinical conditions but no suggestion that a new unique illness was associated with service during the Gulf War. Additionally, no Gulf War exposure was uniquely implicated as a cause for post-war morbidity. Numerous large, controlled studies of US Gulf War veterans' hospitalizations, often involving more than a million veterans, have been conducted. They revealed an increased post-war risk for mental health diagnoses, multi-symptom conditions and musculoskeletal disorders. Again, these data failed to demonstrate that Gulf War veterans suffered from a unique Gulf War-related illness. The sparsely available ambulatory care reports documented that respiratory and gastrointestinal complaints were quite common during deployment. Using perhaps the most reliable data, controlled mortality studies have revealed that Gulf War veterans were at increased risk of injuries, especially those due to vehicular accidents. In general, healthcare utilization data are now exhausted. These findings have now been incorporated into preventive measures in support of current military forces. With a few diagnostic exceptions such as amyotrophic lateral sclerosis, mental disorders and cancer, it now seems time to cease examining Gulf War veteran morbidity and to direct future research efforts to preventing illness among current and future military personnel.
27
Watson-Borg, Bette E., David K. Conn e Claire Checkland. "FC3: “Empowering Health & Social Service Providers in Addressing Social Isolation & Loneliness in Older Adults”". International Psychogeriatrics 35, S1 (dezembro de 2023): 66. http://dx.doi.org/10.1017/s1041610223001011.
Texto completo da fonteResumo:
“Social isolation among older adults is associated with increased change of premature death; depression; dementia, disability from chronic diseases; poor mental health; increased use of health and support services; reduced quality of life; poor general health; and an increased number of falls.” (National Academies of Sciences, Engineering, and Medicine (2020).Without question, the global pandemic has significantly exacerbated both the prevalence and awareness of social isolation and loneliness as a growing health and societal challenge for older populations.“Because of growing calls for Canada’s health-care systems to identify, prevent and mitigate loneliness as part of COVID-19-related public health efforts, there is a unique opportunity to build capacity to identify and intervene with older adults who are experiencing social isolation or loneliness.” National Institute on Aging (2022).Over the past two decades, the Canadian Coalition for Seniors’ Mental Health (CCSMH) has developed a number of internationally recognized clinical guidelines in support of mental health for older adults. CCSMH is responding to the growing mental health crisis of isolation and loneliness with the development of evidence-based guidelines, to support the vital work of health and social service providers across Canada. The focus of these guidelines is to develop a broad range of evidence-based, manageable, and stepped care approaches to identify and address social isolation and loneliness in older adults. It is recognized that this topic is extremely complex and vast in potential scope. Through the guidance of a national working group of experts, these guidelines will draw upon both academic and grey literature, as well as on the experience of a diversity of health and social service providers, older adults, and their caregivers. This project will also provide guidance, promoting wellness and reducing the risk of social isolation with targeted messaging, knowledge translation and useful tools for supporting social connection among those at highest risk.This presentation will share the Guidelines’ preliminary recommendations, as well as data from two national surveys alongside other insights gained from ongoing research and stakeholder engagement.
28
Sugianli, Adhi Kristianto, e Ida Parwati. "PENGANGKAAN (KUANTIFIKASI) PERIKSAAN PULASAN GRAM DI BERBAGAI JENIS BAHAN PEMERIKSAAN". INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 17, n.º 1 (26 de março de 2018): 44. http://dx.doi.org/10.24293/ijcpml.v17i1.1048.
Texto completo da fonteResumo:
In a clinical microbiology laboratory the Gram staining is used to classify bacteria on the basis of their forms, sizes, cellularmorphologies, and Gram reactions. Additionally it is a critical test for rapid presumptive diagnosis of infectious agents and serves toassess the quality of clinical specimens. Several methods of Gram staining quantification are already applied: Canadian Coalition forQuality in Laboratory Medicine (CCQLM), Clinical Microbiology Proficiency Testing (CMPT), and World Health Organization (WHO).Each method consists of several criteria for quantification and its interpretation, such as neutrophil cell (polymorphonuclear cells),squamous epithelial cell, and number of microorganisms. Those methods aren't limited in sputum specimen, but also could be used forother specimen such as urine, vaginal discharge, and other body fluids. These methods are also could be used as screening for specimenbefore it is continued into further testing. Even though there is several limitation for each method, quantification method of Gramstaining could be provide better diagnostic value in microbiology laboratory as an early detection in the examination to get betterdiagnosis as well as treatment.
29
Hoffman, Brian F. "Looking at Legislative and Judicial Views of Psychic Trauma - Fluctuating Recognition and Discrimination". Canadian Journal of Psychiatry 40, n.º 8 (outubro de 1995): 479–83. http://dx.doi.org/10.1177/070674379504000809.
Texto completo da fonteResumo:
Objective To describe how Canadian courts and legislation have viewed psychic or emotional trauma in the past century and the principles that are used. Methods The author reviews major trends in legislation and judicial findings pertaining to emotional trauma and gives examples of the fluctuating and ambivalent recognition by the courts. Results The courts have progressed from refusing to acknowledge emotional trauma, to accepting emotional trauma when accompanied by physical trauma, and finally acknowledging emotional trauma even in the absence of physical injury and the “indirect” emotional trauma suffered by the relatives of victims. However, from time to time, the courts or legislation may appear to deny the distress, dysfunction or the rights of a person who suffers significant emotional symptoms after an injury. This occurred recently in Ontario where injured persons in motor vehicle accidents who suffered emotional trauma were not allowed to sue for compensation from June 1990 to January 1994. Combined efforts by a coalition of mental health professionals with victims of trauma at least partially reversed the discriminatory laws. Conclusions Psychiatrists must continue to play a vital role in the education of the courts, politicians and the public about the realities of emotional trauma and mental illness and their long-term impact so that fair compensation can be assessed by the courts and discriminatory legislation reversed.
30
Oueslati, B., M. Oumaya e R. Bouzid. "Prescribing Tricyclic Antidepressants in the Elderly". European Psychiatry 41, S1 (abril de 2017): S661. http://dx.doi.org/10.1016/j.eurpsy.2017.01.1117.
Texto completo da fonteResumo:
IntroductionAlthough not recommended as a first-line treatment for old patients with depressive, anxiety or somatic symptom disorders, we continue seeing tricyclic antidepressants being frequently prescribed.ObjectivesTo estimate the prevalence and to assess the implementation of safety measures related to the prescription of such molecules in the elderly. To explain their choice as a first-line treatment.MethodsWe included all new patients aged 65 years or over between 1st January 2011 and 31st December 2015 whom, were prescribed an antidepressant. Recommendations of the Canadian coalition for seniors’ mental health, of the world federation of societies of biological psychiatry and of the national institute for health and care excellence were our evaluation tools. We compared tricyclic receivers to those having newer antidepressants to try to understand the choice of tricyclics as a first-line treatment.ResultsEighty patients were included. Mean age was of 75 years. 46% were prescribed a tricyclic as a first line treatment. Depressive disorders were the most diagnosed ones (79%) followed by anxiety disorders (14%) and somatic symptom disorders (7%). An electrocardiogram was not performed to all patients prior to the initiation of the tricyclic nor at anytime later. 11% continued being prescribed tricyclics in spite of contraindications. Only a low economic level was significantly related to their choice as a first-line treatment (P = 0.001).ConclusionsTricyclics’ prescribing rate was high. Safety measures were not applied for all patients. Regular availability of newer antidepressants in public health structures and a better awareness of antidepressants prescribing guidelines in the elderly are mandatory.Disclosure of interestThe authors have not supplied their declaration of competing interest.
31
Rabheru, Kiran, David K. Conn, Claire Checkland e Daria Parsons. "401 - Cannabis and Older Adults". International Psychogeriatrics 33, S1 (outubro de 2021): 28–29. http://dx.doi.org/10.1017/s1041610221001605.
Texto completo da fonteResumo:
The National Cannabis Survey results indicates that cannabis consumption among older adults has been accelerating at a much faster pace than other age groups in Canada. Internationally, an increasing number of countries and U.S. states have also legalized medical and non-medical cannabis.More than 1500 physicians, nurse practitioners, other healthcare providers, healthcare students, older adults and caregivers of older adults responded to a needs assessment survey on Cannabis and Older Adults distributed by the Canadian Coalition for Seniors’ Mental Health (CCSMH) in the fall of 2020.Responses showed that 89% of physicians and nurse practitioners and 76% of other healthcare providers are aware of older patients in their practice using cannabis. Despite this fact, only 39% of physicians and nurse practitioners and 26% of other healthcare providers feel strongly or very strongly that they have sufficient knowledge and expertise to address older patients’ and theircaregivers’ questions about cannabis.Older adults who responded to the survey indicated that their most common reasons for using cannabis were pain, sleep and anxiety. Fifty-one percent responded that they had talked to their doctor or healthcare provider about cannabis but 41% of those older adults stated that their doctor or healthcare provider were unable to answer their questions. Older adults reported they access information on cannabis from the internet (45%), physicians (40%), friends and family (34%), cannabis stores and clinics (28%), the media (24%), and other healthcare providers (16%). Fifty-four percent of older adult respondents who use cannabis do so with a prescription or medical authorization from their physician/nurse practitioner for medical/therapeutic reasons. One quarter of respondents indicated they use cannabis for non-medical reasons (for recreational use).Although there is a reported gap in knowledge regarding cannabis and older adults, physicians, nurse practitioners, other healthcare providers and healthcare students all reported they are eager to learn more about how to talk with patients, how to authorize and prescribe cannabis appropriately, how to mitigate risks and assess for cannabis use disorder in older adults. CCSMH will be launching a physician- accredited e-learning course on Cannabis and Older Adults in January 2022.
32
Webb, Carolyn, e Debbie Field. "Momentum is building for a school food program for Canada". Canadian Food Studies / La Revue canadienne des études sur l'alimentation 9, n.º 3 (17 de outubro de 2022): 1–3. http://dx.doi.org/10.15353/cfs-rcea.v9i3.618.
Texto completo da fonteResumo:
We’re at a tipping point towards our goal of ensuring that all children and youth can access healthy food at school. With momentum building for a Canada-wide school food program, and with many provinces and territories making their own investments and developing programs, we have a collective and unprecedented opportunity to influence the design and direction of school food programs, policy and funding for Canada and impact the lives of children and communities across the country.
The Coalition for Healthy School Food is very excited to welcome this edition of the Canadian Association for Food Studies Journal, which includes four articles on the issue of youth and food. We’re so pleased to see research on this theme that will inform the development of school food initiatives across the country.
33
Chiu, Patrick, Susan Duncan e Nora Whyte. "Charting a Research Agenda for the Advancement of Nursing Organizations’ Influence on Health Systems and Policy". Canadian Journal of Nursing Research 52, n.º 3 (9 de junho de 2020): 185–93. http://dx.doi.org/10.1177/0844562120928794.
Texto completo da fonteResumo:
Nursing organizations across Canada play a significant role in influencing and shaping public policy. 2020, the Year of the Nurse and the Midwife, is an opportune time not only to support nurses in building policy leadership but also to explore opportunities to better understand and strengthen the policy advocacy work of nursing organizations. Given various social, political, and economic forces, the nature of organized nursing across Canada is changing significantly. We draw on recent key national and global events including our systematic inquiry into Canada’s 2019 federal election, the Year of the Nurse and Midwife, and the Coronavirus pandemic to examine how Canadian nursing organizations respond in highly complex and evolving contexts. We use our observations to offer a vision and chart a research agenda for the advancement of nursing organizations’ influence on health systems and policy. Specifically, we focus on three key areas including examining nursing organizations’ policy agendas and spheres of influence; nursing organizations’ decision-making around policy advocacy tactics and engagement approaches; and the impact of policy advocacy coalitions and networks on nursing organizations’ influence.
34
Roberts, Janet Hatcher. "COALITION BUILDING AND PUBLIC OPINION". International Journal of Technology Assessment in Health Care 15, n.º 1 (janeiro de 1999): 15–21. http://dx.doi.org/10.1017/s0266462399015147.
Texto completo da fonteResumo:
The process of technology assessment is evolving. The process of policy development for technology is the least understood in the cycle of technology assessment. The process of policy development, which should involve extensive consultation and a broad-based research and evaluation program, is often fraught with difficulties and can cause further analysis or the assessment process to come grinding to a halt. This article reviews some social, political, and ethical issues and the role of civil society in influencing the technology assessment process for new reproductive technologies in Canada. It is written from the perspective of one of the Deputy Directors of Research and Evaluation for the Royal Commission on New Reproductive Technologies and highlights the strengths and difficulties of technology assessment when civil society and technology assessment come face to face. A brief update by a policy analyst in Health Canada on the current situation of legislation on new reproductive technologies has been provided and is included at the end of this article.
35
Comber, Scott, Kyle Clayton Crawford e Lisette Wilson. "Competencies physicians need to lead – a Canadian case". Leadership in Health Services 31, n.º 2 (8 de maio de 2018): 195–209. http://dx.doi.org/10.1108/lhs-06-2017-0037.
Texto completo da fonteResumo:
Purpose Emerging evidence correlates increased physician leadership effectiveness with improved patient and healthcare system outcomes. To maximize this benefit, it is critical to understand current physician leadership needs. The purpose of this study is to understand, through physicians’ self-reporting, their own and others’ most effective and weakest leadership skills in relation to the LEADS leadership capabilities framework. Design/methodology/approach The authors surveyed 209 Canadian physician leaders about their perceptions of their own and other physicians’ leadership abilities. Thematic analysis was used, and the results were coded deductively into the five LEADS categories, and new categories emerging from inductive coding were added. Findings The authors found that leaders need more skills in the areas of Engage Others and Lead Self, and an emergent category of Business Skills, which includes financial competency, budgeting, facilitation, etc. Further, Achieve Results, Develop Coalitions and Systems Transformation are skills least reported as needed in both self and others. Originality/value The authors conclude that LEADS, in its current form, has a gap in the competencies prescribed, namely, “Business Skills”. They recommend the development of a more comprehensive LEADS framework that includes such skills as financial literacy/competency, budgeting, facilitation, etc. The authors also found that certain dimensions of LEADS are being overlooked by physicians in terms of importance (Systems Transformation, Achieve Results, Develop Coalitions), and this warrants greater investigation into the reasons why these skills are not as important as the others (Engage Others and Lead Self).
36
Etowa, Josephine, e Ilene Hyman. "Leadership and System Transformation: Advancing the Role of Community Health Nursing". Witness: The Canadian Journal of Critical Nursing Discourse 4, n.º 2 (16 de dezembro de 2022): 5–16. http://dx.doi.org/10.25071/2291-5796.101.
Texto completo da fonteResumo:
It is widely recognized that structural and social determinants of health (SDoH) account for a large proportion of health inequities in Canada. According to the Public Health Agency of Canada (PHAC), many health actors are required to provide leadership and direction in tackling health inequities. In this paper we argue that community health nurses (CHNs) are well situated to play a critical role in health system transformation in Canada. CHNs are known for having a holistic and collaborative approach with competencies beneficial for the reduction of health inequities. However, to become more consistently effective advocates of health equity, CHNs require competencies in the principles of equity and social justice, community engagement, communication, coalition building, and system transformation. Having a critical mass of CHNs with appropriate leadership skills in knowledge generation and mobilization, advocacy, and collaboration is fundamental to effectively addressing health inequities in Canada.
37
Carloni, Tabitha. "Abstracts from the 2022 Annual Scientific Meeting of the Canadian Academy of Geriatric Psychiatry and Canadian Coalition for Seniors’ Mental Healths". Canadian Geriatrics Journal 26, n.º 3 (1 de setembro de 2023): 412–42. http://dx.doi.org/10.5770/cgj.26.678.
Texto completo da fonte
38
McNally, M., L. Rock, M. Gillis, S. Bryan, C. Boyd, F. Kraglund e B. Cleghorn. "Reopening Oral Health Services during the COVID-19 Pandemic through a Knowledge Exchange Coalition". JDR Clinical & Translational Research 6, n.º 3 (27 de abril de 2021): 279–90. http://dx.doi.org/10.1177/23800844211011985.
Texto completo da fonteResumo:
Background: The COVID-19 novel coronavirus closed oral health care in Nova Scotia (NS) Canada in March 2020. Preparing for a phased reopening, a knowledge exchange coalition (representing government, academia, hospitals, oral health professions, and regulators) developed return-to-work (RTW) guidelines detailing the augmentation of standard practices to ensure safety for patients, oral health care providers (OHPs), and the community. Using online surveys, this study explored the influence of the RTW guidelines and related education on registered NS OHPs during a phased return to work. Methods: Dissemination of R2W guidelines included website or email communiques and interdisciplinary education webinars that coincided with 2 RTW phases approved by the government. Aligned with each phase, all registered dentists, dental hygienists, and dental assistants were invited to complete an online survey to gauge the influence of the coalition-sponsored education and RTW guidelines, confidence, preparedness, and personal protective equipment use before and after the pandemic. Results: Three coalition-sponsored multidisciplinary webinars hosted 3541 attendees prior to RTW. The response to survey 1 was 41% (881/2156) and to survey 2 was 26% (571/2177) of registrants. Survey 1 (82%) and survey 2 (89%) respondents “agreed/strongly agreed” that R2W guidelines were a primary source for guiding return to practice, and most were confident with education received and had the skills needed to effectively treat patients during the COVID-19 pandemic. Confidence and preparedness improved in survey 2. Gowns/lab coat use for aerosol-generating procedures increased from 26% to 93%, and the use of full face shields rose from 6% to 93% during the pandemic. Conclusions: A multistakeholder coalition was effective in establishing and communicating comprehensive guidelines and web-based education to ensure unified reintegration of oral health services in NS during a pandemic. This multiorganizational cooperation lay the foundation for responses to subsequent waves of COVID-19 and may serve as an example for collaboratively responding to future public health threats in other settings. Knowledge Transfer Statement: The return-to-work strategy that was developed, disseminated, and assessed through this COVID-19 knowledge exchange coalition will benefit oral health practitioners, professional regulators, government policy makers, and researchers in future pandemic planning.
39
Manafò, Elizabeth, Lisa Petermann, Rebecca Lobb, Deb Keen e Jon Kerner. "Research, Practice, and Policy Partnerships in Pan-Canadian Coalitions for Cancer and Chronic Disease Prevention". Journal of Public Health Management and Practice 17, n.º 6 (2011): E1—E11. http://dx.doi.org/10.1097/phh.0b013e318215a4ae.
Texto completo da fonte
40
Politis, C., e D. Keen. "Lessons Learned From Canada in Working Together to Support Indigenous Health and Wellness". Journal of Global Oncology 4, Supplement 2 (1 de outubro de 2018): 132s. http://dx.doi.org/10.1200/jgo.18.23600.
Texto completo da fonteResumo:
Background and context: First Nations, Inuit and Métis bear a disproportionate burden of cancer in Canada. In the spirit of truth and reconciliation, and to have the greatest impact, it is important for nonindigenous and indigenous partners to work together, and reflect on lessons learned in collaborating, to support First Nations, Inuit and Métis health and wellness. Aim: In response to the national Truth and Reconciliation Commission Calls to Action, the Canadian Partnership Against Cancer committed to understanding how collaborative projects funded through the Coalitions Linking Action and Science for Prevention (CLASP) initiative were successful in bringing together diverse groups - both indigenous and nonindigenous - to create and apply culturally-relevant cancer prevention approaches. Strategy/Tactics: Seven projects funded through the CLASP initiative, from 2009 to 2016, brought together over 275 First Nations, Inuit, or Métis communities, schools, and organizations with government, nongovernment, and academic partners in collaborative coalitions. The projects addressed cancer prevention issues prioritized by First Nations, Inuit, and Métis (e.g., unhealthy eating and physical inactivity) through approaches that were holistic and culturally-relevant, such as utilizing intergenerational knowledge sharing, incorporating mental wellness, and supporting existing capacity within communities. Program/Policy process: Over 30 knowledge products developed by the projects were reviewed to identify preliminary lessons learned about partner collaboration. Preliminary lessons learned were verified and expanded upon through nine key informant interviews with CLASP partners. Key informant interviews were informed by four advisors representing indigenous and nonindigenous leaders and partners. The refined set of lessons learned were finalized through qualitative analysis and validated through a conference session and one-day workshop with CLASP partners and First Nations, Inuit, and Métis community leaders. Outcomes: Twenty-seven lessons learned that describe how nonindigenous and First Nations, Inuit and Métis CLASP partners worked together to develop and put into practice culturally-appropriate cancer prevention approaches were identified. The lessons learned were grouped into six themes: 1. respectful relationships; 2. engagement with indigenous communities; 3. addressing accountability requirements, decision-making, and governance; 4. community direction; 5. supports and resources; 6. communication and knowledge exchange. What was learned: The actionable lessons learned are intended to guide future relationship building and engagement between nonindigenous partners and First Nations, Inuit and Métis partners. It is intended that these lessons will be beneficial to collaborative cancer prevention efforts around the world and inform broader system change leading to a reduction in indigenous cancer burden disparities.
41
McGetrick, Jennifer Ann, Kim D. Raine, T. Cameron Wild e Candace I. J. Nykiforuk. "Advancing Strategies for Agenda Setting by Health Policy Coalitions: A Network Analysis of the Canadian Chronic Disease Prevention Survey". Health Communication 34, n.º 11 (11 de junho de 2018): 1303–12. http://dx.doi.org/10.1080/10410236.2018.1484267.
Texto completo da fonte
42
Mireles, Luis Ramon. "Occupational Safety and Health on the U.S.-Mexico Border". NEW SOLUTIONS: A Journal of Environmental and Occupational Health Policy 13, n.º 1 (maio de 2003): 115–20. http://dx.doi.org/10.2190/5cdm-pmer-6jd9-952r.
Texto completo da fonteResumo:
A number of trade agreements were adopted in the 1990s that promised economic growth for Mexico. The most significant was the North American Free Trade Agreement (NAFTA), which promotes open trade between Mexico, the United States, and Canada. Like WTO, NAFTA focuses on the economic aspects of trade. Occupational safety and health issues were not specifically addressed by NAFTA. Despite the presence of domestic regulatory systems, concerns over working conditions persist on both sides of the U.S.-Mexico border and the workforces face similar health problems. The upsurge in trade between the United States and Mexico must be accompanied by an international commitment to occupational safety and health in border areas. If government agencies cannot or will not intervene to reduce rates of workplace injuries and illnesses, civil coalitions must assume this role.
43
Politis, C., e D. Keen. "Critical Success Factors for Promoting Healthy Food Environments and Healthy Eating Through Local Policy Changes: Learning From Canada". Journal of Global Oncology 4, Supplement 2 (1 de outubro de 2018): 132s. http://dx.doi.org/10.1200/jgo.18.12600.
Texto completo da fonteResumo:
Background and context: Policies implemented at the local level can create healthier environments that enable individuals to engage in healthier, cancer preventive behaviors - such as healthy eating. Policies support cancer preventive behaviors in a sustainable and often cost-effective manner. Many theoretical frameworks exist to describe the policy process; however in practice, policy development is often considered a complex and unfamiliar mechanism to the cancer prevention and health promotion community. Aim: To identify and better understand the critical success factors underlying cancer prevention policy success, the Canadian Partnership Against Cancer analyzed the policy outcomes - focused on food environments and healthy eating - from their pan-Canadian funding initiative Coalitions Linking Action and Science for Prevention (CLASP). Strategy/Tactics: Four projects funded through the CLASP initiative, from 2009 to 2016, have yielded 260 policy outcomes related to improving food environments and healthy eating. The policy changes were the result of evidence-based interventions implemented at the local level (i.e., municipalities, schools/child care, and workplaces). Program/Policy process: Over 220 knowledge products and evaluation documents were reviewed to identify food environment and healthy eating policy outcomes and key lessons learned. The policy outcomes were analyzed and categorized according to: a) implementation setting (municipality, school/child care, workplace); and b) policy lever addressed. Policy lever categories were sourced from the World Cancer Research Fund's (WCRF) NOURISHING Framework. Ten key informant interviews were conducted with former project members to refine and validate the lessons learned. Lessons learned were organized into a final list of critical success factors and themed into overarching categories. Outcomes: The majority of the food environment and healthy eating policy outcomes from CLASP occurred in workplace settings (n=133) and municipalities (n=111), and the least in schools/child care settings (n=16). The most frequent NOURISHING policy lever was “Offer healthy food and set standards in public institutions and other specific settings” primarily through policies to ban the sale of energy drinks (n=83) and implementing nutrition standards (n=58). Ten critical success factors were identified and described within three categories: people (n=3); tools (n=3); and approaches and ways of working (n=4). What was learned: A key takeaway from this work was a combination of cross-sectoral partnerships, tools and evidence, and collaborative ways of working were crucial to advance food environment and healthy eating policy change in municipalities, schools and child care settings, and workplaces. By utilizing the international WCRF NOURISHING Framework, it is intended that the lessons learned from this policy work in a Canadian context can inform local-level cancer prevention policy efforts around the world.
44
Plotnikoff, R. C., P. Lightfoot, S. McFall, C. Spinola, S. T. Johnson, T. Prodaniuk, G. Predy, M. S. Tremblay e L. Svenson. "Child Health Ecological Surveillance System (CHESS) for childhood obesity: a feasibility study". Chronic Diseases and Injuries in Canada 30, n.º 3 (junho de 2010): 95–106. http://dx.doi.org/10.24095/hpcdp.30.3.04.
Texto completo da fonteResumo:
Objective To assess the feasibility of employing an ecologically guided childhood obesity relevant surveillance system. Methods Cross-sectional qualitative and quantitative data were collected from 31 organizational representatives across 28 unique organizations and/or departments from three purposively sampled communities in the Capital Health Region in Alberta, Canada. Results All the organizational representatives surveyed reported awareness of childhood obesity and 36% reported participation in child obesity initiatives. Data to support a surveillance system are available but not in a suitable format, and privacy legislation present significant barriers. Interest in developing and sustaining an ecologically based surveillance system was low (18%). Conclusion Due to the heterogeneity of available data and limited vision for the development and implementation of a surveillance system, the application of an ecologically based surveillance system relevant to childhood obesity may be constrained. Broad-based awareness of childhood obesity by a wide range of organizations could assist in establishing an effective coalition to address this issue over the long term by supporting the establishment of a surveillance system.
45
Skinner, J. H. C., e S. J. Bobbili. "Coaches' knowledge and awareness of spit tobacco use among youth athletes: results of a 2009 Ontario survey". Chronic Diseases and Injuries in Canada 32, n.º 3 (junho de 2012): 149–55. http://dx.doi.org/10.24095/hpcdp.32.3.05.
Texto completo da fonteResumo:
Introduction Public health professionals have become concerned that spit tobacco (ST) use among athletes is increasing. However, little is known about the issue in Canada, particularly among youth. Methods The Not to Kids Coalition and the Coaches Association of Ontario surveyed coaches regarding ST knowledge and awareness and their perceived roles as coaches in influencing ST use among their athletes. Surveys were distributed electronically to individuals who coached male and female youth aged 9 to 18 years in baseball, basketball, football, soccer, and track and field, in Ontario. Results Almost all of the surveyed coaches responded correctly to questions about the health effects of ST use, and about 80% of respondents answered correctly to the question about legislation associated with ST and youth. Conclusion Most coaches are interested in receiving information about ST, particularly the health effects of ST use and how to prevent ST use among athletes. Multiple formats should be used to provide information to coaches, including both electronic and hard copy materials.
46
Johnson, Rebecca. "Introduction". Constitutional Forum / Forum constitutionnel 19, n.º 1, 2 & 3 (16 de maio de 2012): 2011. http://dx.doi.org/10.21991/c9jd5z.
Texto completo da fonteResumo:
In Vancouver’s downtown eastside, just down from the Carnegie Community Centre on East Hastings Street, stands Insite. Funded by Vancouver Coastal Health, Insite is a supervised safe injection site for illegal drug users—currently the only such site in North America. It is also at the centre of a heated political and legal struggle over the boundary between health and crime. InPHS Community Services Society v Canada (AG) , the courts have been articulating that struggle in the language of federalism, division of powers and interjurisdictional immunity. Insite, in the courtroom and in the media, raises a host of questions not only about the boundaries of provincial and federal powers, but also about drugs, harm, crime, health, poverty, community, the economy, urban planning, equality, epidemiology, social programming, race, gender, coalition building and municipal politics. Quite the menu of legal, social, and political possibility. In this Issue ofConstitutional Forum, we have drawn together a series of papers that were generated in the context of a pedagogical encounter at the University of Victoria, one that had students and faculty engaged in a collective exploration of the Insite case.
47
Jasinski, Mary-Anne. "Helping Children to Learn at Home: A Family Project to Support Young English-Language Learners". TESL Canada Journal 29 (3 de outubro de 2012): 224. http://dx.doi.org/10.18806/tesl.v29i0.1119.
Texto completo da fonteResumo:
The Coalition for Equal Access to Education (CEAE) is a Calgary-based nonprofit organization committed to working with community, education, and government stakeholders to promote access to quality, equitable education and services for K-12 English-as-a-second-language (ESL) learners. CEAE is active in developing innovative projects, research publications, and informing policy and decision-makers on issues that affect education and services for children and youth. In addition, the organization engages in community development initiatives through literacy development support for ethnocultural children and youth, leadership training on active parental involvement, and promotion of systemic change and cultural competence. In its work to address the complex needs of ESL children, families, and the professionals who support them, the CEAE has developed Helping Children Learn at Home, a parents’ program that supports ethnocultural parents in creating healthy learning environments in the home, in understanding better and addressing their young children’s learning needs, learning about the Canadian education system, and contributing to decision-making processes in schools and in the community that affects their children’s educational success. This article describes the program and the pilot session completed in February 2011. The evaluation phase included feedback from the participants, the CEAE staff, and the curriculum developers in order to produce and publish a completed version of the document, which will be available for use by other agencies.
48
Campbell, Norm RC, Raj Padwal, Ross T. Tsuyuki, Alexander A. Leung, Alan Bell, Janusz Kaczorowski e Sheldon W. Tobe. "Ups and downs of hypertension control in Canada: critical factors and lessons learned". Revista Panamericana de Salud Pública 46 (2 de setembro de 2022): 1. http://dx.doi.org/10.26633/rpsp.2022.141.
Texto completo da fonteResumo:
ABSTRACT As the leading risk for death, population control of increased blood pressure represents a major challenge for all countries of the Americas. In the early 1990’s, Canada had a hypertension control rate of 13%. The control rate increased to 68% in 2010, accompanied by a sharp decline in cardiovascular disease. The unprecedented improvement in hypertension control started around the year 2000 when a comprehensive program to implement annually updated hypertension treatment recommendations started. The program included a comprehensive monitoring system for hypertension control. After 2011, there was a marked decrease in emphasis on implementation and evaluation and the hypertension control rate declined, driven by a reduction in control in women from 69% to 49%. A coalition of health and scientific organizations formed in 2011 with a priority to develop advocacy positions for dietary policies to prevent and control hypertension. By 2015, the positions were adopted by most federal political parties, but implementation has been slow. This manuscript reviews key success factors and learnings. Some key success factors included having broad representation on the program steering committee, multidisciplinary engagement with substantive primary care involvement, unbiased up to date credible recommendations, development and active adaptation of education resources based on field experience, extensive implementation of primary care resources, annual review of the program and hypertension indicators and developing and emphasizing the few interventions important for hypertension control. Learnings included the need for having strong national and provincial government engagement and support, and retaining primary care organizations and clinicians in the implementation and evaluation.
49
Buxton, Meredith, Brian Alexander, Donald Berry, Webster Cavenee, Howard Colman, John de Groot, Benjamin Ellingson et al. "RTID-11. GBM AGILE: A GLOBAL, PHASE 2/3 ADAPTIVE PLATFORM TRIAL TO EVALUATE MULTIPLE REGIMENS IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA". Neuro-Oncology 22, Supplement_2 (novembro de 2020): ii195—ii196. http://dx.doi.org/10.1093/neuonc/noaa215.816.
Texto completo da fonteResumo:
Abstract Developing new therapies for patients with glioblastoma (GBM) requires focused interaction between industry, academia, nonprofits, patient advocacy, and health authorities, and novel approaches to clinical trials. GBM Adaptive Global Innovative Learning Environment (GBM AGILE) Trial was designed by over 130 global key opinion leaders in consultation with health authorities to provide an optimal mechanism for phase 2/3 development in GBM. The Sponsor of GBM AGILE is the Global Coalition for Adaptive Research, whose mission is to accelerate the development of treatments rare and deadly diseases by serving as sponsor of innovative trials. GBM AGILE is an international platform trial designed to evaluate multiple therapies in newly diagnosed and recurrent GBM. Its goals are to identify effective therapies for GBM and match effective therapies with patient subtypes, with data generated to support regulatory filing for new drug applications. Bayesian response adaptive randomization is used within subtypes of the disease to assign participants to investigational arms based on their performance. The primary endpoint is overall survival. The trial is being conducted under a master Investigational New Drug Application/Clinical Trial Agreement and Master Protocol, allowing multiple drugs from different companies to be evaluated simultaneously and/or over time. The plan is to add experimental therapies as new information is identified and remove therapies as they complete their individual evaluation against a common control. GBM AGILE received IND approval from the FDA in April 2019, screening its first patient in June 2019. As of June 2020 over 200 patients have been screened. Expansion to Canada, Europe, China, and Australia is also underway. There is currently one investigational arm under evaluation in the trial, with two additional arms to be added in Q4 2020/ Q1 2021. Clinical trial information: NCT03970447.
50
Buxton, Meredith Becker, Brian Michael Alexander, Donald A. Berry, Webster K. Cavenee, Howard Colman, John Frederick De Groot, Benjamin M. Ellingson et al. "GBM AGILE: A global, phase II/III adaptive platform trial to evaluate multiple regimens in newly diagnosed and recurrent glioblastoma." Journal of Clinical Oncology 38, n.º 15_suppl (20 de maio de 2020): TPS2579. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.tps2579.
Texto completo da fonteResumo:
TPS2579 Background: Glioblastoma (GBM) is an aggressive brain tumor with few effective therapies and is invariably fatal. Developing new therapies for patients with GBM requires focused interaction between industry, academia, nonprofits, patient advocacy, and health authorities, and novel approaches to clinical trials. Industry is wary of developing drugs for GBM due to the high failure rate and high cost of drug development. GBM Adaptive Global Innovative Learning Environment (GBM AGILE) Trial was designed by over 130 global key opinion leaders in consultation with health authorities to provide an optimal mechanism for phase II/III development in GBM. The Sponsor of GBM AGILE is the Global Coalition for Adaptive Research (GCAR), a non-profit organization. GCAR’s mission is to speed the discovery and development of treatments for patients with rare and deadly diseases by serving as sponsor of innovative trials. Methods: GBM AGILE is an international, seamless phase II/III platform trial designed to evaluate multiple therapies in newly diagnosed and recurrent GBM. Its goals are to identify effective therapies for GBM and match effective therapies with patient subtypes, with data generated to support regulatory filing for new drug applications. Bayesian response adaptive randomization is used within subtypes of the disease to assign participants to investigational arms based on their performance. The primary endpoint is overall survival. The trial is being conducted under a master Investigational New Drug Application/Clinical Trial Agreement and Master Protocol, allowing multiple drugs/drug combinations from different pharmaceutical companies to be evaluated simultaneously and/or over time. The plan is to add experimental therapies as new information is identified and remove therapies as they complete their individual evaluation against a common control. GBM AGILE received IND approval from the FDA in April 2019, enrolling its first patient in June 2019. Site activation is ongoing in the US, with approximately 40 US planned. The trial received CTA approval from Health Canada in January 2020. Expansion to Europe, China, and Australia is also underway. Clinical trial information: NCT03970447 .